Filter
531
Filtered Results: 531
Text search:
biontech
Featured
Recommendations
65
New Publications
76
Language
Document type
No document type
159
Studies & Reports
127
Guidelines
108
Fact sheets
56
Manuals
38
Strategic & Response Plan
16
Training Material
7
Infographics
6
Resource Platforms
5
Situation Updates
4
Online Courses
3
Brochures
1
Videos
1
Countries / Regions
India
43
Global
22
Germany
19
Brazil
13
South Africa
11
Russia
11
Nepal
10
Ukraine
10
Latin America and the Carribbean
9
Argentina
9
Mozambique
8
Middle East and North Africa
7
Africa
6
Rwanda
5
Bangladesh
5
Nigeria
4
Tanzania
4
West and Central Africa
4
Western and Central Europe
4
Paraguay
4
Zambia
4
Colombia
3
Kenya
3
China
3
Chile
3
Cameroon
3
South–East Asia Region
3
East and Southern Africa
3
Ethiopia
3
Ecuador
3
Myanmar / Burma
3
Thailand
2
Syria
2
Peru
2
Malawi
2
Zimbabwe
2
Philippines
2
USA
2
Asia
2
Spain
2
Vietnam
2
Uganda
2
Namibia
2
Angola
2
Botswana
2
South Sudan
2
El Salvador
1
Turkey
1
Ghana
1
Benin
1
Sierra Leone
1
Kazakhstan
1
Iran
1
Senegal
1
Afghanistan
1
Guinea
1
Haiti
1
Cambodia
1
Guinea-Bissau
1
Congo, Democratic Republic of
1
Eastern Europe and Central Asia
1
France
1
United Kingdom
1
Portugal
1
Belarus
1
Papua New Guinea
1
Sudan
1
Yemen
1
Central African Republic
1
Libya
1
Iraq
1
Somalia
1
Liberia
1
Madagascar
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
200
Clinical Guidelines
33
Pharmacy & Technologies
21
Key Resources
20
Women & Child Health
8
Public Health
6
Capacity Building
1
Annual Report MEDBOX
1
Toolboxes
COVID-19
179
AMR
32
NTDs
27
Rapid Response
23
TB
23
Planetary Health
22
HIV
18
Pharmacy
17
Refugee
16
Ebola & Marburg
12
Health Financing Toolbox
11
Global Health Education
7
Social Ethics
6
Caregiver
6
Mental Health
5
Cholera
5
Conflict
5
NCDs
4
Specific Hazards
3
Disability
2
Malaria
1
Zika
1
Polio
1
Ukrainian Title: ІНСТРУКЦІЯ ДЛЯ ПІДТРИМКИ ІНТЕГРАЦІЇ ФАРМАЦЕВТИЧНИХ ПРАЦІВНИКІВ-БІЖЕНЦІВ З УКРАЇНИ
This information is based on data provided by the All-Ukrainian Pharmaceutical Chamber (AUPC) to the International Pharmaceutic...
The roadmap describes the actions needed to
achieve the three development goals for TB
vaccines set by the WHO:
1. A safe, effective and affordable TB vaccine
for adolescents and adults.
2. An affordable TB vaccine for neonates and
infants with improved safety and efficacy.
3. A therapeutic v...
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
The EYE strategy is a comprehensive and long-term strategy built on lessons learned that aims at ending yellow fever epidemics by 2026, and consists of three strategic objectives:
protect at-risk populations;
prevent international spread; and
contain outbreaks rapidly.
Antibiotics 2022, 11(3), 329; https://doi.org/10.3390/antibiotics11030329.
The authors found that the most-represented antibiotics on the Rwandan market were amoxicillin, co-trimoxazole and cloxacillin. No counterfeit antibiotics were found in this study. However, substandard batches with moderate ...
Accessed November, 2017
Front Chem. 2021; 9: 622286.
Published online 2021 Mar 12. doi: 10.3389/fchem.2021.622286
Presentation is current through November 21, 2014 and will be updated every Friday by 5pm. For the most up-to-date information, please visit www.cdc.gov/ebola.
*Presentation contains materials from CDC, MSF, and WHO
In this edition, the Antimicrobial Resistance chapter discusses the growing, dangerous trend of antimicrobial resistance and the potential catastrophic consequences on global health.
Chapter 1 of Frontier 2017: Emerging Issues of Environmental Concern
Robust clinical research capacity in low- and middle-income countries is key to stemming the spread of epidemics, according to a new report from the International Vaccines Task Force (IVTF). The report lays out how to develop the political support, financing and coordination required to build this c...
This document builds on the Background document prepared for the September 4-5, 2014 Consultation. It includes proposed elements to consider during the development of a framework to assist decision-making at global and national level.
The aim of the document is to assist Member States and releva...
Polymerase Chain Reaction (PCR) has significantly helped in early diagnosis and commencement of specific interventions for diseases control. It also plays a critical role in understanding the disease epidemiology and unraveling the transmission dynamics of the disease. This manual intends to p...
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc)...
Health Care Facilities (HCFs) are primarily responsible for management of the healthcare waste generated within the facilities, including activities undertaken by them in the community. The health care facilities, while generating the waste are responsible for segregation, collection, in-house trans...
The WHO Guide on Oral Cholera Vaccines in Mass Immunization Campaigns provides guidance on the planning and implementation of oral cholera vaccine (OCV) campaigns. It covers key aspects such as when and where to use OCVs, vaccine specifications, and recommendations for use in endemic areas, outbreak...
This short paper aims to identify key evidence gaps in our knowledge of livestock- and fisheries-linked antimicrobial resistance in the developing world, and to document on-going or planned research initiatives on this topic by key stakeholders.
The antimicrobial resistant (AMR) infections in anima...
This document serves to provide interim guidance/ recommendations to carry out mpox surveillance activities mainly case investigation, contact tracing and isolation. For the development of this document WHO, UKHSA and CDC guidelines were referred to and adopted within the country context.
РУКОВОДСТВО ПО БИОЛОГИЧЕСКОЙ БЕЗОПАСНОСТИ ЛАБОРАТОРНЫХ ИССЛЕДОВАНИЙ ПРИ ТУБЕРКУЛЕЗЕ.
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
